AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Global Partners LP
Video analysis: GLP
All videosNo video analysis for this stock yet. Request one from our team.
News: GLP
Are Investors Undervaluing Global Partners (GLP) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It
Company plans to integrate telemedicine into its verified health intelligence platform and opens a ten-seat Founding Physician Cohort spanning GLP-1 and metabolic care, hormone and menopause health, and physician-directed therapies for men and women. MIAMI, FL / ACCESS Newswire / September 15, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today announced plans to integrate telemedicine capabilities into its verified health intelligence platform and opened applications for its Founding Physician Cohort.
Making Getting Skinny Taste Good: Cava CEO On The GLP-1 Boom
From smaller portions and adults ordering kids meals to more protein and Mediterranean-style eating, Cava CEO Brett Schulman breaks down how GLP-1s are changing customer behavior. Check out our daily newsletter!
Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s
LLY's immunology portfolio is gaining ground, with steady revenue growth, pipeline expansion and acquisitions broadening its next wave.
‘US Consumption of Alcoholic Beverages Is at Historic Lows': Heineken Hires GLP-1 Pitchwoman to Sell Beer
Heineken's US chief executive Maggie Timoney went on Bloomberg this week to explain why Serena Williams was named the first global ambassador for Heineken 0.
Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule
MannKind Corporation (NASDAQ:MNKD) shares are trading lower on Wednesday as traders react to the company's entry into a licensing and collaboration deal tied to an inhaled, rapid-acting GLP-1 program.
Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program
SAN FRANCISCO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, announced a new, independent cost savings model that examined the measurable clinical and economic value of Omada's GLP-1 program.1 GlobalData , a data analytics and consulting company, recently published a report estimating greater disease reduction and higher cumulative cost savings with Omada's GLP-1 solutions compared to standard care.
CAPL or GLP: Which Energy MLP Has the Stronger Investment Case?
CAPL and GLP bring distinct strengths in income, scale, leverage and valuation, setting up a closer comparison for energy MLP investors.
Similar companies
-
FLEX LNG Ltd
FLNG
·
New York Stock Exchange
Compare
-
Dnow Inc.
DNOW
·
New York Stock Exchange
Compare
-
Enerflex Ltd.
EFXT
·
New York Stock Exchange
Compare
-
World Kinect Corporation
WKC
·
New York Stock Exchange
Compare
-
Expro Group Holdings N.V.
XPRO
·
New York Stock Exchange
Compare
-
Nextdecade Corp
NEXT
·
NASDAQ
Compare